Table of Contents

Despite the promises of new technologies, ECG use is increasing and its clinical applications are diversifying.

The prognosis for patients with noncardiac chest pain is excellent, yet functional outcome is generally poor because many patients continue to believe their pain has a cardiac source.

Different beta blockers have different effects on cardiac output and heart rate, and some may diminish detrimental arterial changes induced by hypertension. A long-term preventive effect against coronary artery disease remains to be demonstrated.

A chain of simple-to-make observations quickly determines the location of the lesion — the primary goal in early assessment.

Concomitant use of calcium-channel blockers may prevent nephrotoxicity and permit use of full therapeutic doses of amphotericin B in systemic fungal infection.

With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.

Doppler echocardiography is emerging as an excellent noninvasive way to assess diastolic function, and its array of clinical applications is expanding.

Clinical perceptions of PACNS have changed dramatically in the last 5 years, prompting a reappraisal of the 1987 diagnostic criteria and current approaches to treatment

Lung and heart-lung transplantation is no longer experimental, but a reasonable option in many heart and lung disorders previously deemed fatal.

An update of the clinical management of viral hepatitis, based on recent developments in screening and diagnosis.

Migraine onset was found to parallel that of myocardial infarction and changes in platelet aggregability, plasma cortisol, and plasma catecholamines.